A recent meta-analysis of pooled individual patient-level data, researchers found reduced effectiveness of the quadrivalent live-attenuated influenza vaccine (LAIV4) against influenza A/H1N1pdm09 compared with inactivated influenza vaccine (IIV) in children and adolescents.
Investigators at the Huazhong University of Science and Technology conducted a meta-analysis of published clinical trials that evaluated IVIG therapy in acute myocarditis.
FDA has approved Amgen’s romiplostim to treat pediatric patients ages 1 year and older with immune thrombocytopenia for a minimum of six months and who have had an insufficient response to corticosteroids, immune globulin or splenectomy.
The Human Vaccine Project aims to understand how the human immune system can develop longer-lasting protection against influenza.
FDA has approved Xospata (gilteritinib) to treat adult patients with relapsed or refractory acute myeloid leukemia with a certain genetic mutation.
A study conducted by MIT and the Massachusetts Eye and Ear has found glaucoma may be an autoimmune disorder.
FDA granted Sanofi Pasteur’s Adacel Tdap absorbed vaccine expanded indication to include repeat vaccinations for tetanus, diphtheria and pertussis.
A new survey shows more than 40 percent of Americans haven’t been vaccinated against the flu and aren’t planning to be due to misconceptions.
A new study shows pregnant women hospitalized in the ICU with flu are four times more likely to deliver prematurely and four-and-a-half times more likely to have a baby of low birth weight.
The U.S. Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) has awarded $293 million in awards to primary healthcare clinicians and students through the National Health Service Corps (NHSC) and Nurse Corps programs.
CMS has developed the Oncology Care Model (OCM) to provide higher quality and more highly coordinated oncology care at the same or lower cost to Medicare.
CMS takes steps to enhance and strengthen its oversight and quality transparency of accrediting organizations.
